Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

OBESITY AND METABOLIC DISEASE

Diving deep—multipronged investigations into RIPK1 as a risk factor for obesity

A recent study by Karunakaran et al. suggests that RIPK1 is important in obesity and related metabolic traits. With genetic variation associated with expression and the risk of obesity, and repression of activity leading to a favourable metabolic profile in an obesogenic model, is there evidence for a potential therapeutic role?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Triangulation of evidence around RIPK1 as a candidate for a role in body-composition-related cellular pathways.

References

  1. Mifflin, L., Ofengeim, D. & Yuan, J. Nat. Rev. Drug Discov. 19, 553–571 (2020).

    Article  CAS  Google Scholar 

  2. Degterev, A., Ofengeim, D. & Yuan, J. Proc. Natl Acad. Sci. USA 116, 9714–9722 (2019).

    Article  CAS  Google Scholar 

  3. Karunakaran, D. et al. Nat. Metab. https://doi.org/10.1038/s42255-020-00279-2 (2020).

  4. Munafo, M. R. & Davey-Smith, G. Nature 553, 399–401 (2018).

    Article  CAS  Google Scholar 

  5. Lawlor, D. A., Tilling, K. & Davey Smith, G. Int. J. Epidemiol. 45, 1866–1886 (2017).

    PubMed Central  Google Scholar 

  6. Timpson, N. J., Greenwood, C. M. T., Soranzo, N., Lawson, D. J. & Richards, J. B. Nat. Rev. Genet. 19, 110–124 (2018).

    Article  CAS  Google Scholar 

  7. Wellcome Trust Case Control Consortium. Nature 447, 661–678 (2007).

    Article  Google Scholar 

  8. Frayling, T. M. et al. Science 316, 889–894 (2007).

    Article  CAS  Google Scholar 

  9. Claussnitzer, M. et al. N. Engl. J. Med. 373, 895–907 (2015).

    Article  CAS  Google Scholar 

  10. Lotta, L. A. et al. Cell 177, 597–607.e9 (2019).

    Article  CAS  Google Scholar 

  11. Laakso, M. et al. J. Lipid Res. 58, 481–493 (2017).

    Article  CAS  Google Scholar 

  12. Davies, R. W. et al. Eur. J. Hum. Genet. 21, 1417–1422 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

N.J.T. is a Wellcome Trust Investigator (202802/Z/16/Z) and the PI of the Avon Longitudinal Study of Parents and Children (MRC and WT 217065/Z/19/Z); is supported by the University of Bristol NIHR Biomedical Research Centre (BRC-1215–2001) and the MRC Integrative Epidemiology Unit (MC_UU_00011); and works within the CRUK Integrative Cancer Epidemiology Programme (C18281/A19169).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas John Timpson.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Timpson, N.J. Diving deep—multipronged investigations into RIPK1 as a risk factor for obesity. Nat Metab 2, 997–998 (2020). https://doi.org/10.1038/s42255-020-00284-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-020-00284-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing